Bieber, T. ., Beck, L., Pink, A., Saeki, H., Eichenfeld, L., Werfel, T., Rosholm, A., Ropke, M. and Paller, A. . (2021) ‚ÄúNeutralizing interleukin-13 increases skin microbial diversity: results from a Phase 3, randomized, double-blind, placebo-controlled trial of tralokinumab in adult patients with atopic dermatitis‚ÄĚ, SKIN The Journal of Cutaneous Medicine, 5(6), p. s56. doi: 10.25251/skin.5.supp.56.